EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 26-Oct-2026 02:17 ET (26-Oct-2026 06:17 GMT/UTC)

New philosophical framework reframes moral distress in healthcare

Tokyo University of Science
Peer-Reviewed Publication

Moral distress is the suffering healthcare professionals experience when they cannot act according to what they believe is right because of external constraints. Despite decades of study, how clinicians recognize what is ethically important has received little attention. Now, researchers from Japan propose a philosophical framework that offers a new account of moral distress, and proposes that moral sensitivity is a cultivated capacity to perceive ethical reasons for action. Their work suggests clinicians with greater moral sensitivity may paradoxically be more vulnerable to moral distress.

Journal: Nursing Ethics

Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy

European Society of Cardiology
Reports and Proceedings

Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

Jumping for health: School-based plyo-hiit aims to improve muscle-to-fat ratio in kids

Zhejiang University
Peer-Reviewed Publication

Researchers are testing whether a school-based exercise program—combining plyometric jumping drills with high-intensity interval training (HIIT)—can improve the muscle-to-fat ratio (MFR) in children aged 9 to 12.

Journal: World Journal of Pediatrics

Reducing antibiotic courses by two weeks could be possible in patients with infective endocarditis

European Society of Cardiology
Reports and Proceedings

A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective endocarditis. This was the main finding from the POET-II trial presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants

European Society of Cardiology
Reports and Proceedings

Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot Line session today at ESC Congress 20261 and published simultaneously in the New England Journal of Medicine.

Methylation puts parasites in motion

Ludwig-Maximilians-Universität München
Peer-Reviewed Publication

LMU researchers identify a molecular mechanism that enables single-celled parasites to switch on the machinery they need to move and invade host cells.

Journal: Nature Communications

RS virus admissions among infants fall sharply following vaccine rollout

University of Copenhagen
Peer-Reviewed Publication

A new study from the University of Copenhagen and Nordsjaellands Hospital suggests that Denmark's new RSV vaccination programme for pregnant women may have dramatically reduced the number of infants hospitalised with the virus.

Journal: The Lancet Regional Health - Europe

Temperature extremes can increase risk of heart failure hospitalization

American College of Cardiology
Peer-Reviewed Publication

Heart failure hospitalization risk increases after short-term exposure to cold spells, lower ambient temperatures and higher ambient temperatures, according to a study published in JACC, the flagship journal of the American College of Cardiology, and simultaneously presented at ESC Congress 2026. The increase in hospitalizations, seen in Sweden, shows how temperature extremes can contribute to sudden worsening of illness and the need for health systems to respond to and prepare for environmental stressors.

Journal: Journal of the American College of Cardiology
Meeting: ESC Congress 2026

Human blood marker points to a compound that slows ALS in mice

Nagoya University
Peer-Reviewed Publication

Researchers in Japan found that blood levels of the metabolic substance N-acyl taurines (NATs) correlate with Amyotrophic lateral sclerosis (ALS) progression. They also demonstrated that PF-04457845, a compound already shown to be safe in humans, slows motor decline in ALS mouse models. These findings suggest a potential new therapeutic option.

Journal: JCI Insight